Different Types of Antibiotics and their Applications
Antibiotics, also known as antibacterials, are types of medications that destroy or slow down the growth of bacteria. In 1929, Alexander Fleming identified penicillin, the first chemical compound with antibiotic properties. Some of the common antibiotics are Penicillins, Cephalosporins, Carbapenems, Macrolides, Aminoglycosides, Quinolones, Sulfonamides and, Tetracyclines etc. General principles of antibiotic prescribing are use: First-line antibiotics first, Reserve broad spectrum antibiotics for indicated conditions only, prescribe antibiotics for bacterial infections if Symptoms are significant or severe.
The antibiotics market generated sales of US$42 billion in 2009 globally, representing 46% of sales of anti-infective agents (which also include antiviral drugs and vaccines) and 5% of the global pharmaceutical market1. However, the antibiotics market is maturing; it showed an average annual growth of 4% over the past 5 years, compared with a growth of 16.7% and of 16.4% for antiviral drugs and vaccines, respectively.
The cephalosporin class of antibiotics is the largest in terms of sales, generating $11.9 billion in 2009, led by sales of the latest generation of drugs in this class (cefcapene (Flomox; Shionogi), ceftriaxone (Rocephin; Roche) and cefuroxime (Zinnat; GlaxoSmithKline). This class represents 28% of the total antibiotic market, and sales showed a growth of 3.4% over the past 5 years. With sales of $7.9 billion and 19% of the antibiotic market share in 2009, the second largest drug class is the broad-spectrum penicillins, which showed a growth of 5% between 2005 and 2009. The third largest drug class — the fluoroquinolones — had sales of $7.1 billion in 2009, accounting for 17% of the antibiotic market in 2009, and also showed an average growth of 5% between 2005 and 2009. By contrast, as generic versions of an increasing number of macrolides — which had $4.8 billion in sales in 2009 — became available, sales of this class declined by 5% between 2007 and 2009. Overall, the rate of patent expiry of leading antibiotics in the market is set to increase, with several of the current top-selling products facing patent expiry between 2010 and 2016. These include levofloxacin (Levaquin; Johnson & Johnson), moxifloxacin (Avelox; Bayer/Merck) and linezolid (Zyvox; Pfizer), which are expected to lose patent protection in 2011, 2014 and 2016, respectively.
There are now hundreds of different types of antibiotics, but most of them can be broadly classified into six groups. These are outlined below.
Penicillin – widely used to treat a variety of infections, including skin infections, chest infections and urinary tract infections.
Cephalosporins – can be used to treat a wide range of infections, but are also effective for treating more serious infections, such as septicaemia and meningitis.
Aminoglycosides – tend to only be used to treat very serious illnesses such as septicaemia, as they can cause serious side effects, including hearing loss and kidney damage; they break down quickly inside the digestive system, so they have to be given by injection, but are also used as drops for some ear or eye infections.
Tetracyclines – can be used to treat a wide range of infections; commonly used to treat moderate to severe acne and rosacea, which causes flushing of the skin and spots.
Macrolides – can be particularly useful for treating lung and chest infections; can also be a useful alternative for people with a penicillin allergy or to treat penicillin-resistant strains of bacteria.
Fluoroquinolones – broad-spectrum antibiotics that can be used to treat a wide range of infections.
- Hypocholesterolemic agents
- Immunosuppressive agents
- Anti-migraine agents
- Cephalosporins (1,2, 3, 4, 5 generations)
Related Conference of Different Types of Antibiotics and their Applications
Different Types of Antibiotics and their Applications Conference Speakers
- Advances in Antibiotic Treatment
- Advances in Infectious Antibiotics
- Antibiotic Prophylaxis
- Antibiotic Regulatory Affairs
- Antibiotic Resistance: Opportunities and Challenges
- Antibiotics and Mechanism of Action
- Antibiotics for Cancer
- Antibiotics for Diabetes
- Antibiotics for Emerging and Re-emerging Diseases
- Antibiotics in Different Industries
- Antibiotics: In Pregnancy and Lactation
- Antibiotics: Market Analysis & Business Opportunities
- Clinical Trials of Antibiotics
- Different Types of Antibiotics and their Applications
- Drug Discovery and Novel Delivery Technologies
- Micro Organisms in Recent Drug Discovery
- Modern Antibiotics for Various Diseases and Infections
- The Emergence of Antimicrobial Resistance
Are you interested in
- Antibiotic resistance in a one-health context - Antimicrobials 2019 (Japan)
- Antibiotic resistance: An overview - Antimicrobials 2019 (Japan)
- Antibiotics by application - Antimicrobials 2019 (Japan)
- Antibiotics by chemical class - Antimicrobials 2019 (Japan)
- Antibiotics by Drug origin - Antimicrobials 2019 (Japan)
- Antibiotics Pipeline landscape - Antimicrobials 2019 (Japan)
- Antibiotics with spectrum - Antimicrobials 2019 (Japan)
- Antibiotics, microbes and models - Antimicrobials 2019 (Japan)
- Antibiotics: An overview - Antimicrobials 2019 (Japan)
- Antibiotics: Different Countries - Antimicrobials 2019 (Japan)
- Antibiotics: Market landscape - Antimicrobials 2019 (Japan)
- Antibiotics: Mechanism of action - Antimicrobials 2019 (Japan)
- Developing new drugs: Academic and Industrial innovations - Antimicrobials 2019 (Japan)
- Market Challenges - Antimicrobials 2019 (Japan)
- Market trends - Antimicrobials 2019 (Japan)
- Microbial virulence - Antimicrobials 2019 (Japan)
- Veterinary Drug - Antimicrobials 2019 (Japan)